Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NutraLife Biosciences, Inc. (NLBS) had Return on Equity of 50.88% for the most recently reported fiscal quarter, ending 2022-09-30.
| Income Statement Financials | |
$0.12M |
|
$-1.18M |
|
$0.02M |
|
$0.09M |
|
$0.56M |
|
$-0.45M |
|
$-0.73M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-0.45M |
|
$-0.29M |
|
175.72M |
|
175.72M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.87M |
|
$2.23M |
|
$5.16M |
|
$6.03M |
|
$4.45M |
|
$0.01M |
|
$3.90M |
|
$8.35M |
|
$-2.32M |
|
$-3.40M |
|
$-2.32M |
|
176.62M |
|
| Cash Flow Statement Financials | |
$-1.14M |
|
$-1.23M |
|
$2.67M |
|
$0.14M |
|
$0.43M |
|
$0.30M |
|
$0.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.20 |
|
-- |
|
-- |
|
-0.00 |
|
-1.10 |
|
82.12% |
|
-386.68% |
|
-386.68% |
|
-- |
|
-1023.01% |
|
-1023.01% |
|
$-1.14M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.06 |
|
2.36 |
|
38.08 |
|
|
Return on Equity |
50.88% |
34.60% |
|
-19.53% |
|
51.10% |
|
$-0.01 |
|
$-0.01 |
|
$-0.01 |
|